---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-26-000502"
form_type: "8-K"
ticker: "KALA"
cik: "0001479419"
company_name: "KALA BIO, Inc."
filed_at: "2026-01-23T23:59:59+00:00"
generated_at: "2026-05-16T08:22:49.007697+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# KALA BIO receives Nasdaq bid price deficiency notice; 180-day compliance period until July 20, 2026

## Summary
- Letter dated Jan 20, 2026; closing bid price below $1.00 for 30 consecutive business days (Dec 3, 2025–Jan 16, 2026).
- Must maintain closing bid price ≥$1.00 for at least ten consecutive business days during the compliance period to regain compliance.
- If not cured by July 20, 2026, may be eligible for an additional 180-day period if other Nasdaq listing standards are met.
- No immediate impact on stock listing; shares continue trading on Nasdaq subject to other requirements.

## SEC filing metadata
- accession: 0001829126-26-000502
- form_type: 8-K
- ticker: KALA
- cik: 0001479419
- company_name: KALA BIO, Inc.
- filed_at: 2026-01-23T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479419/000182912626000502/0001829126-26-000502-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479419/000182912626000502/kalabio_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-26-000502
- JSON: https://secwatch.observer/filing/0001829126-26-000502.json
- Plain text: https://secwatch.observer/filing/0001829126-26-000502.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.